How is goserelin typically given (administered)?
Goserelin is administered subcutaneously (injection under the skin) and the dose depends on several factors, including the condition being treated, the particular regimen being used and the overall health of the patient. Patients may have an allergic-type reaction to treatment with goserelin; however, this is uncommon. If patients experience difficulty breathing, rapid heart rate, or lightheadedness, they should contact their healthcare provider. How are patients typically monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with goserelin. Patients may undergo physical examinations, scans or other measures to assess side effects and response to therapy. Patients will also be monitored for a phenomenon called “flare” in which levels of the hormones testosterone or estrogen may surge during initial therapy with goserelin. The elevated levels of hormones can cause a sudden increase in symptoms, such as bone pain in patients
